Qiagen (QGEN) Gets a Buy from Berenberg Bank
Berenberg Bank analyst Harry Gillis has maintained a Buy rating on Qiagen (QGEN) with a price target of €46.00. Gillis, a 2-star analyst, has an average return of 0.6% and a 61.90% success rate. Qiagen also received a Buy rating from Deutsche Bank's Jan Koch, while TD Cowen maintained a Hold rating on November 10.
In a report released yesterday, Harry Gillis from Berenberg Bank maintained a Buy rating on Qiagen, with a price target of €46.00.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
According to TipRanks, Gillis is a 2-star analyst with an average return of 0.6% and a 61.90% success rate. Gillis covers the Healthcare sector, focusing on stocks such as Qiagen, Swedish Orphan Biovitrum AB, and Moderna.
In addition to Berenberg Bank, Qiagen also received a Buy from Deutsche Bank ‘s Jan Koch in a report issued yesterday. However, on November 10, TD Cowen maintained a Hold rating on Qiagen (NYSE: QGEN).
